MX2021014111A - Proceso para la preparacion de epimeros de fosforamidita de galnac. - Google Patents

Proceso para la preparacion de epimeros de fosforamidita de galnac.

Info

Publication number
MX2021014111A
MX2021014111A MX2021014111A MX2021014111A MX2021014111A MX 2021014111 A MX2021014111 A MX 2021014111A MX 2021014111 A MX2021014111 A MX 2021014111A MX 2021014111 A MX2021014111 A MX 2021014111A MX 2021014111 A MX2021014111 A MX 2021014111A
Authority
MX
Mexico
Prior art keywords
preparation
epimers
galnac
galnac phosphoramidite
phosphoramidite
Prior art date
Application number
MX2021014111A
Other languages
English (en)
Inventor
Kurt Puentener
Simon Adolf Breitler
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2021014111A publication Critical patent/MX2021014111A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/08Polyoxyalkylene derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La invención comprende un proceso para la preparación de un epímero de fosforamidita de GalNAc de fórmula I, en donde R1 es un grupo protector de hidroxilo, n es un número entero de 0 a 10 y m es un número entero de 0 a 20, enantiómeros y/o isómeros ópticos correspondientes del mismo y el uso del proceso para la preparación de conjugados de oligonucleótidos de complejo GalNAc.
MX2021014111A 2019-05-20 2020-05-18 Proceso para la preparacion de epimeros de fosforamidita de galnac. MX2021014111A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19175309 2019-05-20
PCT/EP2020/063749 WO2020234208A1 (en) 2019-05-20 2020-05-18 Process for the preparation of galnac phosphoramidite epimers

Publications (1)

Publication Number Publication Date
MX2021014111A true MX2021014111A (es) 2021-12-10

Family

ID=66625050

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021014111A MX2021014111A (es) 2019-05-20 2020-05-18 Proceso para la preparacion de epimeros de fosforamidita de galnac.

Country Status (13)

Country Link
US (1) US20220259248A1 (es)
EP (1) EP3972984A1 (es)
JP (1) JP2022533220A (es)
KR (1) KR20220010496A (es)
CN (1) CN113840828B (es)
AR (1) AR118949A1 (es)
AU (1) AU2020278797A1 (es)
CA (1) CA3134494A1 (es)
IL (1) IL288116A (es)
MX (1) MX2021014111A (es)
SG (1) SG11202110680PA (es)
TW (1) TW202110483A (es)
WO (1) WO2020234208A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023143571A1 (zh) * 2022-01-30 2023-08-03 大睿生物医药科技(上海)有限公司 含有n-乙酰半乳糖胺的靶向配体
WO2024075760A1 (ja) * 2022-10-05 2024-04-11 第一三共株式会社 2分岐型n-アセチル-d-ガラクトサミン構造を有する化合物の製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX369556B (es) * 2015-08-06 2019-11-12 Hoffmann La Roche Procesos para la preparacion de derivados acidos de n-acetilgalactosamina (galnac).
AR106683A1 (es) * 2015-11-16 2018-02-07 Hoffmann La Roche FOSFORAMIDITA DE AGRUPACIÓN DE GalNAc
WO2018215049A1 (en) 2017-05-23 2018-11-29 F. Hoffmann-La Roche Ag Process for galnac oligonucleotide conjugates

Also Published As

Publication number Publication date
IL288116A (en) 2022-01-01
KR20220010496A (ko) 2022-01-25
CN113840828B (zh) 2024-01-16
US20220259248A1 (en) 2022-08-18
JP2022533220A (ja) 2022-07-21
CA3134494A1 (en) 2020-11-26
EP3972984A1 (en) 2022-03-30
TW202110483A (zh) 2021-03-16
CN113840828A (zh) 2021-12-24
AR118949A1 (es) 2021-11-10
SG11202110680PA (en) 2021-10-28
WO2020234208A1 (en) 2020-11-26
AU2020278797A1 (en) 2021-10-07

Similar Documents

Publication Publication Date Title
MX2018005733A (es) Fosforamidita de agrupacion de n-acetilgalactosamina (galnac).
MX2021001433A (es) Nuevos compuestos heterociclicos como inhibidores de la monoacilglicerol lipasa.
MX2021014111A (es) Proceso para la preparacion de epimeros de fosforamidita de galnac.
CR20210247A (es) Nuevos compuestos heterocíclicos
MY197439A (en) Phosphorus?containing polycarboxylate superplasticizer and method for making same
BR112021020637A2 (pt) Derivados de tetra-hidro-1h-ciclopenta[cd]indeno como inibidores de fator -2(alfa) induzível por hipóxia
CR20200416A (es) Nuevos compuestos heterocíclicos
CR20220118A (es) Nuevos inhibidores heterocíclicos de monoacilglicerol lipasa (magl)
UY32025A (es) Derivados sustituídos de la 6-cloro-2-hidroxi-3-(3,4-dioxo-ciclobut-1-enil-amino)-n-metoxi-n-metil-bencen-sulfonamida, solvatos, hidratos o sales farmacéuticamente aceptables de los mismos, proceso de preparación, composiciones y aplicaciones.
MX2017011821A (es) Silanos y composiciones curables que contienen dichos silanos como reticulantes.
MX2020006290A (es) Dinucleotidos ciclicos como agonistas de sting.
MX2022002311A (es) Compuestos de 4,4a,5,7,8,8a-hexapirido[4,3-b][1,4]oxazin-3-ona como inhibidores de monoacilglicerol lipasa (magl).
MX2023012477A (es) Compuestos heterociclicos.
CR20220116A (es) Compuestos heterocíclicos
MX369556B (es) Procesos para la preparacion de derivados acidos de n-acetilgalactosamina (galnac).
NZ746906A (en) Oxaborole esters and uses thereof
ZA202305624B (en) Amorphous form of a complement component c5a receptor
CR20220478A (es) Derivados de benzodiazepinas como pam de gaba a gamma 1
MX2020013827A (es) Proceso de preparacion de compuestos triciclicos.
MX2021000625A (es) Dinucleotidos ciclicos como agonistas de sting.
EP4169925A3 (en) Process to make n-substituted tetrahydrothienopyridine derivatives
WO2016097657A3 (fr) Dimères polyaromatiques, leur procédé de préparation et utilisation
MX2021007511A (es) Procedimiento para la preparacion de anilinas sustituidas.
BR112022008113A2 (pt) Formas sólidas de um modulador de receptor s1p
MX2010004624A (es) Oligomeros de organofosfonato.